Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Skye Bioscience Faces Nasdaq Listing Compliance Deficiency Notice
Skye Bioscience (SKYE) has received a Nasdaq deficiency notice because its common stock traded below the $1.00 minimum bid price for 30 consecutive business days, risking its Nasdaq Global Market listing. The company has until September 14, 2026, to regain compliance, possibly through a reverse stock split. Spark, TipRanks’ AI Analyst, rates SKYE as Neutral due to weak financial performance and bearish technical signals, despite some positive offsets from recent earnings calls and Phase 2a data.